Charles Schwab’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Charles Schwab’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-28,500	Closed	-$242K	–	3230
2015 Q1	$242K	Hold	28,500	–	–	﹤0.01%	2907
2014 Q4	$266K	Hold	28,500	–	–	﹤0.01%	2894
2014 Q3	$238K	Hold	28,500	–	–	﹤0.01%	2889
2014 Q2	$330K	Hold	28,500	–	–	﹤0.01%	2816
2014 Q1	$362K	Buy	28,500 +8,000	+39%	+$103K	﹤0.01%	2724
2013 Q4	$222K	Hold	20,500	–	–	﹤0.01%	2929
2013 Q3	$251K	Hold	20,500	–	–	﹤0.01%	2842
2013 Q2	$274K	Buy	+20,500	New	+$264K	﹤0.01%	2762

Other funds holding DSCI

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab's DSCI Position: Q2 2015 in Review

Charles Schwab sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2015, closing a stake of 28,500 shares — an estimated $242K sold.

Charles Schwab first reported a position in DSCI in Q2 2013 and held it in 8 quarters. The position peaked at $362K in Q1 2014. 62 funds tracked by Wall St. Rank hold DSCI as of Q2 2015.

Charles Schwab reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2015 after selling out during the quarter.
Charles Schwab sold 28,500 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2015, an estimated $242K.
Charles Schwab first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 8 quarters.
Charles Schwab's Derma Sciences, Inc. Common Stock (DE) position peaked at $362K in Q1 2014.
62 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2015.

Based on Charles Schwab's 13F filing for Q2 2015, filed 14 Aug 2015.